It also made a $100 million-plus deal to buy Sequence, a telehealth business that can offer virtual prescriptions, where appropriate, to patients for these weight loss drugs
Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)
The neurocircuitry of fear, stress, and anxiety disorders
This article will give you a clear understanding of its important role in modern medicine
Effects of different types of Exercise on Bone Mineral density in Postmenopausal Women: a systematic review and Meta-analysis
Levocarnitine supplementation improves liver function markers and reduces liver fat in NAFLD populations